Lumryz Gains Ground in Narcolepsy Treatment, Reports Avadel
Avadel Pharmaceuticals shared updates on the performance and reception of its new narcolepsy medication, Lumryz.
Source: sleepreviewmag.com
Optum Select News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Optum Select. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Optum Select Today - Breaking & Trending Today
Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial Highlights
08.01.2024 - - Approximately $19 million and $28 million of net revenue from sales of LUMRYZ estimated for the fourth quarter and full year 2023, respectively - - Generated continued robust demand for LUMRYZ with greater than 1,900 patients enrolled in ... Seite 1
Source: wallstreet-online.de